Agenda Topics- Diagnostics Regulatory Updates
- Imaging Based Diagnostics
- Intellectual Property, Reimbursement & HTA Focus
- NGS-Based Diagnostics
- Personalised Breast Cancer Medicine
- Whole Genome Sequencing, The 100,000 Project
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Speakers to dateJames Brenton, Senior Group Leader, Cancer Research UK Charles Cox, Head Genetics Experiment Design and Delivery, GSK Pharmaceuticals Jurgen Eils, Head, German Cancer Research Centre Thomas Krahn, Head of Global Biomarker Research Department, Bayer Pharma Ag Claudia Meinken, European Patent Attorney, Patents and Trademarks for Life Sciences Iain Miller, Co-Founder, Healthcare Strategies Group Scott Palmer, Vice President , Ernst & Young LLP Rosalind Polley, Senior Medical Device Specialist, Medicines & Healthcare Products Regulatory Agency (MHRA) Kristin Ciriello Pothier, Partner & Managing Director/Life Sciences Leader, Ernst and Young LLP Cecilia Schott, Head Personalized Healthcare, Corporate Business Development Global Product & Portfolio Strategy, AstraZeneca Andreas Schuppert, Vice President, Bayer Technology Services GmbH Christoph Turck, Head, Max Planck Institute of Psychiatry
|